The sexual dimorphism associated with pulmonary hypertension corresponds to a fibrotic phenotype
- PMID: 25992281
- PMCID: PMC4405725
- DOI: 10.1086/679724
The sexual dimorphism associated with pulmonary hypertension corresponds to a fibrotic phenotype
Abstract
Although female predominance in the development of all types of pulmonary hypertension (PH) is well established, many clinical studies have confirmed that females have better prognosis and higher survival rate than males. There is no clear explanation of why sex influences the pathogenesis and progression of PH. Using a rat angioproliferative model of PH, which closely resembles the primary pathological changes observed in humans, we evaluated the role of sex in the development and progression of PH. Female rats had a more pronounced increase in medial thickness in the small pulmonary arteries. However, the infiltration of small pulmonary arteries by inflammatory cells was found only in male rats, and this corresponded to increased myeloperoxidase activity and abundant adventitial and medial fibrosis that were not present in female rats. Although the level of right ventricle (RV) peak systolic pressure was similar in both groups, the survival rate in male rats was significantly lower. Moreover, male rats presented with a more pronounced increase in RV thickness that correlated with diffuse RV fibrosis and significantly impaired right cardiac function. The reduction in fibrosis in female rats correlated with increased expression of caveolin-1 and reduced endothelial nitric oxide synthase-derived superoxide. We conclude that, in the pathogenesis of PH, female sex is associated with greater remodeling of the pulmonary arteries but greater survival. Conversely, in males, the development of pulmonary and cardiac fibrosis leads to early and severe RV failure, and this may be an important reason for the lower survival rate among males.
Keywords: caveolin-1; nitric oxide synthase; oxidative stress; superoxide.
Figures
Similar articles
-
Role of endothelial nitric oxide synthase and collagen metabolism in right ventricular remodeling due to pulmonary hypertension.Circ J. 2014;78(6):1465-74. doi: 10.1253/circj.cj-13-1586. Epub 2014 Apr 4. Circ J. 2014. PMID: 24705390
-
ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension.Am J Respir Crit Care Med. 2018 Feb 1;197(3):373-385. doi: 10.1164/rccm.201703-0502OC. Am J Respir Crit Care Med. 2018. PMID: 28910144
-
Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.Am J Respir Cell Mol Biol. 2017 Nov;57(5):615-625. doi: 10.1165/rcmb.2016-0364OC. Am J Respir Cell Mol Biol. 2017. PMID: 28679058 Free PMC article.
-
The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.Naunyn Schmiedebergs Arch Pharmacol. 2006 Sep;373(6):401-14. doi: 10.1007/s00210-006-0082-1. Epub 2006 Aug 1. Naunyn Schmiedebergs Arch Pharmacol. 2006. PMID: 16896805
-
The right ventricle and pulmonary hypertension.Heart Fail Rev. 2016 May;21(3):259-71. doi: 10.1007/s10741-016-9526-y. Heart Fail Rev. 2016. PMID: 26833318 Review.
Cited by
-
Mitochondria as a primary determinant of angiogenic modality in pulmonary arterial hypertension.J Exp Med. 2024 Nov 4;221(11):e20231568. doi: 10.1084/jem.20231568. Epub 2024 Sep 25. J Exp Med. 2024. PMID: 39320470
-
Novel Hemodynamic, Vascular Lesion, and Cytokine/Chemokine Differences Regarding Sex in a Pulmonary Arterial Hypertension Model.Am J Respir Cell Mol Biol. 2024 Oct;71(4):453-463. doi: 10.1165/rcmb.2023-0378OC. Am J Respir Cell Mol Biol. 2024. PMID: 38864769
-
Pathophysiology and new advances in pulmonary hypertension.BMJ Med. 2023 Mar 23;2(1):e000137. doi: 10.1136/bmjmed-2022-000137. eCollection 2023. BMJ Med. 2023. PMID: 37051026 Free PMC article. Review.
-
Sex Differences in Pulmonary Hypertension.Front Aging. 2021 Oct 4;2:727558. doi: 10.3389/fragi.2021.727558. eCollection 2021. Front Aging. 2021. PMID: 35822006 Free PMC article. Review.
-
Cytokine profiling in pulmonary arterial hypertension: the role of redox homeostasis and sex.Transl Res. 2022 Sep;247:1-18. doi: 10.1016/j.trsl.2022.03.013. Epub 2022 Apr 9. Transl Res. 2022. PMID: 35405322 Free PMC article.
References
-
- Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 2003;361:1533–1544. - PubMed
-
- Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987;107:216–223. - PubMed
-
- Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry. Chest 2010;137:376–387. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials